Interestingly, a third potential mechanism by which rapamycin could cause insulin resistance in skeletal muscle was recently described by Blattler et al. (2012), who showed that 2 weeks of rapamycin treatment decreased expression of YY1 target genes, including upstream components of the insulin signaling cascade. This evidence concerns the gene INS and Insulin resistance.